Dr James H Gilbaugh, MD | |
2626 N Webb Rd, Wichita, KS 67226-8110 | |
(316) 636-6100 | |
(316) 636-5813 |
Full Name | Dr James H Gilbaugh |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 37 Years |
Location | 2626 N Webb Rd, Wichita, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952389728 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 04-25103 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wesley Medical Center | Wichita, KS | Hospital |
Fredonia Regional Hospital | Fredonia, KS | Hospital |
Via Christi Hospital-wichita | Wichita, KS | Hospital |
Kingman Community Hospital | Kingman, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wichita Urology Group Pa | 7214904499 | 23 |
News Archive
For scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, what seemed like a disappointing result turned out to be an important discovery.
Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.
Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
The preliminary result from Tripep's rights offering shows that it has been oversubscribed with significant marginal (approximately 150%). Through the offering Tripep will receive approximately 17.8 MSEK before emission costs. The final outcome of the emission will be presented around the 30th of December 2009.
› Verified 6 days ago
Entity Name | Wichita Urology Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639157498 PECOS PAC ID: 7214904499 Enrollment ID: O20040916000316 |
News Archive
For scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, what seemed like a disappointing result turned out to be an important discovery.
Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.
Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
The preliminary result from Tripep's rights offering shows that it has been oversubscribed with significant marginal (approximately 150%). Through the offering Tripep will receive approximately 17.8 MSEK before emission costs. The final outcome of the emission will be presented around the 30th of December 2009.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James H Gilbaugh, MD 2626 N Webb Rd, Wichita, KS 67226-8110 Ph: (316) 636-6100 | Dr James H Gilbaugh, MD 2626 N Webb Rd, Wichita, KS 67226-8110 Ph: (316) 636-6100 |
News Archive
For scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, what seemed like a disappointing result turned out to be an important discovery.
Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.
Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
The preliminary result from Tripep's rights offering shows that it has been oversubscribed with significant marginal (approximately 150%). Through the offering Tripep will receive approximately 17.8 MSEK before emission costs. The final outcome of the emission will be presented around the 30th of December 2009.
› Verified 6 days ago
Dr. Oral E Bass, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 | |
Dr. Christel Orphee Wambi- Kiesse, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 | |
Dr. George F Zakharia, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 | |
William David Mcdonough, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-689-9234 Fax: 316-689-9909 | |
Rodney G Handsfield, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1130 S Clifton Ave, Wichita, KS 67218 Phone: 316-260-4000 Fax: 316-260-1500 | |
Surendra Kolla, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-689-9185 | |
Gregory F Byrd, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2626 N Webb Rd, Wichita, KS 67226 Phone: 316-636-6100 Fax: 316-636-5813 |